We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.9%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.78%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVVC
15351
CALL
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
-16,700
Closed -$10.5K
SVVC
15352
PUT
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
-100
Closed -$63
VHAQ.WS
15353
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
-10,652
Closed -$214
RVLP
15354
CALL
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-11,300
Closed -$6.33K
RVLP
15355
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-51,693
Closed -$29K
RVLP
15356
PUT
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-200
Closed -$112
BTWN
15357
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
-9,918
Closed -$102K
ZYNE
15358
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-25,500
Closed -$8.31K
ZYNE
15359
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-100
Closed -$33
FFTG
15360
DELISTED
FormulaFolios Tactical Growth ETF
FFTG
-20,518
Closed -$504K
FFHG
15361
DELISTED
Formula Folios Hedged Growth ETF
FFHG
-8,264
Closed -$272K
FZT.WS
15362
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
-12,481
Closed -$8.72K
CGRN
15363
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-13,931
Closed -$11.5K
CGRN
15364
PUT
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-1,600
Closed -$1.92K
VCSA
15365
PUT
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
-10
Closed -$136
CELL
15366
CALL
DELISTED
PhenomeX Inc. Common Stock
CELL
-9,000
Closed -$4.41K
CELL
15367
PUT
DELISTED
PhenomeX Inc. Common Stock
CELL
-4,500
Closed -$2.21K
TRTN
15368
CALL
DELISTED
Triton International Limited
TRTN
-95,900
Closed -$7.98M
TRTN
15369
DELISTED
Triton International Limited
TRTN
-367
Closed -$30.6K
TRTN
15370
PUT
DELISTED
Triton International Limited
TRTN
-42,400
Closed -$3.53M
SYNH
15371
CALL
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-28,800
Closed -$1.21M
SYNH
15372
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-33,500
Closed -$1.41M
SYNH
15373
PUT
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-200
Closed -$8.43K
SLVRW
15374
DELISTED
SilverSPAC Inc. Warrant
SLVRW
-13,344
Closed -$906
OTMOW
15375
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
-17,999
Closed -$360

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.